Connect with us

Category 2

OB-GYN innovators to be recognised at Femtech World Awards

Published

on

The Femtech World Awards 2025, delivered in partnership with headline sponsor Planned Parenthood, celebrates the brightest lights in women’s health innovation.

The event celebrates the best examples of leadership, innovation and impact in key areas that affect women’s health and wellbeing.

The OB/GYN Innovation of the Year award recognises a pioneering advancement that has transformed obstetrics and gynecology.

This award, sponsored by Elitone by Elidah, celebrates an innovation that has significantly improved women’s reproductive health, from diagnosis and treatment to overall patient care.

Elidah, a medical equipment manufacturer, serves as a women’s health leader for the home.

Elitone is recognised as the first and only non-intrusive treatment for stress, mixed, and urge bladder leaks.

It remains non-intrusive both physically and in terms of time, allowing individuals to undergo treatment while engaging in other tasks.

The device addresses the common issue of bladder leaks experienced by 1 in 3 women, whether occurring during sneezing and coughing or due to the urgency of an overactive bladder.

Elitone offers devices specifically designed to address and treat these concerns.

Gloria Kolb, CEO and co-founder of Elitone, said: “Being involved in this year’s Femtech Awards is very exciting because it provides a platform to recognise new innovations that are paving the way for women’s health.

“It’s an incredible opportunity to showcase how technology is reshaping healthcare and driving meaningful change for women all around the world.”

The Femtech World Awards are free to enter, with winners and shortlisted entries receiving extensive coverage across all Femtech World platforms.

Winners will also receive a physical award and be interviewed for Femtech World.

Find out more and enter here.

News

WEC Chair calls out Health Minister’s delay on banning BBLs and other harmful cosmetic procedures

Published

on

WEC chair Sarah Owen has criticised delays over a ban on high harm cosmetic procedures, including liquid BBLs.

The Women and Equalities Committee has published a letter from health minister Karin Smyth after the government missed the 18 April deadline to respond to the committee’s report on cosmetic procedures.

The report, published on 18 February, recommended that high harm procedures such as liquid Brazilian butt lifts, known as BBLs, should be banned immediately without further consultation.

MPs said the government is “not moving quickly enough” in introducing a licensing system for non-surgical cosmetic procedures and “should accelerate regulatory action”.

They also warned that “this lack of timely action is fostering complacency in self-regulation” within the industry.

In her letter, Smyth said the Department of Health and Social Care had “taken the decision to first of all focus on introducing legal safeguards for the cosmetic procedures posing the highest risks and I can confirm that we plan to consult on draft regulations in June”.

The letter added:

“Our intention is to issue a formal government response to the WEC report, once our consultation setting out our proposed approach and underpinning legislation is published.

“I acknowledge the concerns around the government’s pace of delivery in this area but, as you will appreciate, this is a complex area of policy and striking the balance between increased patient safety, placing new requirements on businesses and introducing proportionate and enforceable regulation is challenging.

“I recognise that regulation has not kept pace with the expansion of the aesthetics industry and, on that basis, I can assure you that we are committed to implementing licensing in the current parliament.”

Owen, chair of the Women and Equalities Committee and Labour MP, said:

“Further consultation and delay on clamping down on high harm procedures such as liquid BBLs is unacceptable. It allows unscrupulous people to continue to put women at risk and lets down those who have lost loved ones following these practices or who have come to serious harm themselves.

“As WEC’s report warned back in February, procedures that are deemed high risk such as liquid BBLs and liquid breast augmentations, which have already been shown to pose a serious threat to patient safety, should be banned immediately.

“While it is positive to hear a licensing system for non-surgical cosmetic procedures will be introduced within this Parliament, this issue requires faster regulatory progress, particularly in high harm areas, and the Government is not moving quickly enough.

“The Committee previously heard a powerful and shocking testimony from a woman who developed sepsis after having a liquid BBL. Her experience and those of many others provides clear evidence of the need to tackle this evolving wild west.”

A liquid BBL is a non-surgical procedure intended to alter the shape of the buttocks.

Sepsis is a potentially life-threatening response to infection that can lead to organ damage if not treated quickly.

Continue Reading

Pregnancy

Hinge charts pelvic pain breakthrough in latest trial

Published

on

A women’s health intervention that harnesses software, AI and wearables to address pelvic pain, as well as depression, has shown promising results.

Hinge Health’s digital ‘Women’s Pelvic Health Programme’ has reported a 44 per cent reduction in pelvic pain after four weeks of use – and 53 per cent after 12 weeks.

The probability of the intervention group screening for moderate to severe depression was significantly lower by 11 per cent compared to the control group.

Bijal Toprani, pelvic health physical therapist at Hinge Health and co-author of the study, said: “Although women’s pelvic pain is incredibly common, it remains undertreated and as a result, many women are going about their lives suffering in silence.

“This study builds on validated research supporting the efficacy of Hinge Health’s Women’s Pelvic Health program to make a tangible impact for women and improve their quality of life.”

The findings were published in the medical journal, BMC Women’s Health.

One in three women will suffer a pelvic floor disorder in their lifetime.

These disorders occur when pelvic floor muscles become weak or tight. Women with chronic pelvic pain experience a wide range of physical and psychological challenges related to their condition, from urinary urgency and constipation to lower back and hip pain.

Some common causes are muscle strain during pregnancy, trauma or injury to the pelvic floor from surgery or childbirth, hormonal changes with menopause, and stress or anxiety triggering tension in the pelvic floor.

This pain can take a toll on a woman’s overall wellbeing, impacting both their personal and professional lives.

In addition to a lack of awareness around pelvic health issues, inadequate access to pelvic floor specialists makes it difficult for women to find care, making digital solutions essential.

Hinge Health’s 2025 State of MSK Care Report found that while it can take an average of 93 days to see a pelvic floor physical therapist (PT) in person.

“Pelvic floor problems are treatable, however, a major problem is simply access to specialists,” said Dr. Jeff Krauss, CMO at Hinge Health.

“This study is an achievement demonstrating the strengths of our digital Women’s Pelvic Health Program and sends an encouraging message to women that there are clinically-validated, easily-accessible programmes available to help them.”

This observational study examined pain, depression, and anxiety outcomes at four and 12 weeks among participants of a digital women’s pelvic health program compared to a non-participant group. A total of 797 participants were included in the sample.

The company is headquartered in San Francisco.

Continue Reading

Category 2

New Visa programme could boost femtech founders amid investment gap

Published

on

Femtech startups may be able to access a new investment scheme from Visa, which aims to close the funding gap experienced by female founders.

Visa Foundaton has launched the CatalyseHer Programme in the UK and is aiming to provide 500 women entrepreneurs with training and fundraising support to grow their businesses and make them more attractive to investors.

The programme includes training, networking and micro-grants and is aimed at early stage, women-owned businesses.

It is seeking to 500 UK-based female founders to address the gender financing gap facing women entrepreneurs in the UK.

Women entrepreneurs still face barriers when it comes to access to the investments and resources that support innovation.

Women-founded businesses in the UK receive only a two per cent share of total venture capital investments according to the British Business Bank.

Najada Kumbuli, head of investments and partnerships, Visa Foundation said: “Women entrepreneurs play a crucial role in all economies by driving innovation and impact at scale.

“This programme aims to address the main challenges faced by women entrepreneurs and create a ripple effect across many communities in the UK.”

Mandy Lamb, MD in the UK and Ireland at Visa, said: “Women entrepreneurs are critical in developing a more sustainable, equitable future. By addressing barriers and providing access to resources such as funding, mentorship and networking, Visa Foundation can help unlock the potential of women-led businesses to drive further innovation in the UK.”

CatalyseHer is supported by the social enterprise IMCO. See more on the programme here.

Visa also runs the ‘She’s Next’ programme, a global initiative to spotlight women in their efforts to fund, run, and grow their businesses.

Launched in January 2019, it has invested £2.5+m in grants and coaching for female business owners across Europe.

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.